» Articles » PMID: 19489095

Epigenetic Landscaping During HESC Differentiation to Neural Cells

Overview
Journal Stem Cells
Date 2009 Jun 3
PMID 19489095
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms underlying pluripotency and lineage specification from embryonic stem cells (ESCs) are still largely unclear. To address the role of chromatin structure in maintenance of pluripotency in human ESCs (hESCs) and establishment of lineage commitment, we analyzed a panel of histone modifications at promoter sequences of genes involved in maintenance of pluripotency, self-renewal, and in early stages of differentiation. To understand the changes occurring at lineage-specific gene regulatory sequences, we have established an efficient purification system that permits the examination of two distinct populations of lineage committed cells; fluorescence activated cell sorted CD133(+) CD45(-)CD34(-) neural stem cells and beta-III-tubulin(+) putative neurons. Here we report the importance of other permissive marks supporting trimethylation of Lysine 4 H3 at the active stem cell promoters as well as poised bivalent and nonbivalent lineage-specific gene promoters in hESCs. Methylation of lysine 9 H3 was found to play a role in repression of pluripotency-associated and lineage-specific genes on differentiation. Moreover, presence of newly formed bivalent domains was observed at the neural progenitor stage. However, they differ significantly from the bivalent domains observed in hESCs, with a possible role of dimethylation of lysine 9 H3 in repressing the poised genes.

Citing Articles

Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: and Post-grafting Safety Characterization.

Shigyo M, Kobayashi Y, Platoshyn O, Marsala S, Kato Jr T, Takamura N Cell Transplant. 2023; 32:9636897231163232.

PMID: 36959733 PMC: 10041596. DOI: 10.1177/09636897231163232.


Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.

Sart S, Liu C, Zeng E, Xu C, Li Y Eng Life Sci. 2022; 22(11):667-680.

PMID: 36348655 PMC: 9635003. DOI: 10.1002/elsc.202100042.


A large scale mass spectrometry-based histone screening for assessing epigenetic developmental toxicity.

Verhelst S, Van Puyvelde B, Willems S, Daled S, Cornelis S, Corveleyn L Sci Rep. 2022; 12(1):1256.

PMID: 35075221 PMC: 8786925. DOI: 10.1038/s41598-022-05268-x.


Changes in chromatin accessibility landscape and histone H3 core acetylation during valproic acid-induced differentiation of embryonic stem cells.

Baumann C, Zhang X, Zhu L, Fan Y, De La Fuente R Epigenetics Chromatin. 2021; 14(1):58.

PMID: 34955095 PMC: 8711205. DOI: 10.1186/s13072-021-00432-5.


Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.

Yabo Y, Niclou S, Golebiewska A Neuro Oncol. 2021; 24(5):669-682.

PMID: 34932099 PMC: 9071273. DOI: 10.1093/neuonc/noab269.